What does this research mean for the field?

Long-term antihypertensive treatment blunts carotid intima-media thickness progression regardless of drug class, with calcium-channel blockers demonstrating greater efficacy than other classes, whereas the specific benefit of angiotensin II receptor blockers remains inconclusive. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To review the effects of various antihypertensive drug regimens, particularly angiotensin II receptor blockers, on carotid intima-media thickness progression.

June 1, 2009Integrated Blood Pressure ControlOpen Access

Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials

View Full Paper

Ask AI

Bookmark

Why the study?

Do antihypertensive drugs, particularly ARBs, reduce carotid intima-media thickness progression in patients with hypertension or high cardiovascular risk?

Key Points

To review the effects of various antihypertensive drug regimens, particularly angiotensin II receptor blockers, on carotid intima-media thickness progression.
Reviewed 16 double-blind, randomized controlled trials evaluating carotid intima-media thickness via ultrasonography.
Assessed three comparisons: antihypertensive drugs versus placebo or no treatment (5 trials, N=3,215), active antihypertensive regimens (5 trials, N=4,662), and angiotensin II receptor blockers versus other agents (6 trials, N=841).
Long-term antihypertensive therapy consistently blunts the progression of carotid intima-media thickness irrespective of drug class.
Calcium-channel blockers show greater efficacy in blunting carotid intima-media thickness progression compared to diuretics, beta-blockers, and angiotensin-converting enzyme inhibitors.
Angiotensin II receptor blockers show inconsistent protective effects across trials compared with other regimens, which were mostly atenolol-based.

Structured PICO

Do antihypertensive drugs, particularly ARBs, reduce carotid intima-media thickness progression in patients with hypertension or high cardiovascular risk?

Population

8,718 patients across 16 double-blind, randomized, controlled studies with conditions including hypertension, coronary heart disease, asymptomatic carotid artery disease, diabetes, dyslipidemia, and preclinical renal disease.

Intervention

Antihypertensive drugs, including angiotensin-II receptor blockers (ARBs), calcium-channel blockers (CCBs), ACE-inhibitors, beta-blockers, and diuretics.

Comparator

Placebo, no treatment, or other active antihypertensive drug regimens.

Outcome

Carotid intima-media thickness (IMT) progression assessed by ultrasonography.surrogate

Antihypertensive treatment, particularly with calcium-channel blockers, effectively blunts the progression of carotid intima-media thickness, while the specific benefit of ARBs requires further investigation.

Limitations

Limited number of studies available for ARBs
Scarce evidence for ARBs in preventing carotid atherosclerosis progression
A limited fraction of available studies provided reliable information

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

May support CCB preference to slow carotid IMT progression; leaves open ARB comparisons for prospective trials.

Cite This Study

Cesare Cuspidi (2009) studied this question.

synapsesocial.com/papers/6a19d16e54bb2bac6ef65bb1 https://doi.org/10.2147/ibpc.s5174

View Full Paper

Ask AI

Bookmark

Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials

Key Points

Structured PICO

Limitations

Discussion

Implication

Cite This Study

Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials

Key Points

Structured PICO

Limitations

Discussion

Implication

Cite This Study

Also Consider

Also Consider